S 2764 · 118th Congress · Health
Protecting Patient Access to Cancer and Complex Therapies Act of 2023
Bill Progress
✓
Introduced2
Committee3
Senate Vote4
House5
EnactedLatest: Read twice and referred to the Committee on Finance.(2023-09-12)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [S. 2764 Introduced in Senate (IS)] <DOC> 118th CONGRESS 1st Session S. 2764 To amend title XVIII of the Social Security Act to provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES September 12, 2023 Mr. Barrasso introduced the following bill; which was read twice and referred to the Committee on Finance _______________________________________________________________________ A BILL To amend title XVIII of the Social Security Act to provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Protecting Patient Access to Cancer and Complex Therapies Act of 2023''. SEC. 2. REBATE BY MANUFACTURERS FOR SELECTED DRUGS AND BIOLOGICAL PRODUCTS SUBJECT TO MAXIMUM FAIR PRICE NEGOTIATION. (a) Maintaining …
Summarized by Claude AI · Non-partisan · For informational purposes only